Titel: Epigenome Editing in medicine – preferable to Genome Editing? Scientific foundations, legal and ethical analysis, and international perspectives
Beginn:
14.4.2021
Veranstaltungsort:
Im Neuenheimer Feld 130
69120 Heidelberg
Zoom
Weitere Informationen:
https://www.uni-mannheim.de/news/public-workshop-of-the-project-compas ...
In contrast to the vigorous debate on ethical and regulatory aspects of genome editing, epigenome editing has rarely been discussed from an ethical or legal perspective. The project COMPASS-ELSI broadens the scope of this discussion. Within an ethical and a legal subproject, novel applications of gene editing tools such as CRISPR/Cas on the germline as well as on the somatic level are evaluated. The leading research question of COMPASS-ELSI is whether epigenome editing needs to be evaluated differently from genome editing. Furthermore, the project’s goal lies in initiating an ethical and legal debate on epigenome editing. In this workshop, we will present results of our project and discuss them with experts from our international advisory board.
Kontakt:
Karla Alex
karla.alex@med.uni-heidelberg.de
Veranstalter: Section Translational Medical Ethics, National Center for Tumor Diseases at Heidelberg University Hospital, Department of Law at University of Mannheim
Wissenschaftliche Leitung: Prof. Dr. Dr. Eva Winkler, Prof. Dr. Ralf Müller-Terpitz
Schlagworte: Genforschung/-technik, Humangenetik